Clinical Trial: A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Multiple Sclerosis
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Postmarketing Study of Dimethyl Fumarate (Tecfidera; BG00012) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China
Brief Summary:
The primary objective of the study is to assess the efficacy of DMF in Chinese participants with RMS at Week 48.The secondary objectives of the study are to assess the efficacy and safety of DMF in Chinese participants with RMS.
Read more